A_DT
mutation_NN
of_IN
the_DT
glucocorticoid_NN
receptor_NN
in_IN
primary_JJ
cortisol_NN
resistance_NN
._.

The_DT
precise_JJ
molecular_JJ
abnormalities_NNS
that_WDT
cause_VB
primary_JJ
cortisol_NN
resistance_NN
have_VBP
not_RB
been_VBN
completely_RB
described_VBN
._.

In_IN
a_DT
subject_NN
with_IN
primary_JJ
cortisol_NN
resistance_NN
we_PRP
have_VBP
observed_VBN
glucocorticoid_NN
receptors_NNS
-LRB-_-LRB-
hGR_NN
-RRB-_-RRB-
with_IN
a_DT
decreased_VBN
affinity_NN
for_IN
dexamethasone_NN
._.

We_PRP
hypothesize_VBP
that_IN
a_DT
mutation_NN
of_IN
the_DT
hGR_NN
glucocorticoid-binding_JJ
domain_NN
is_VBZ
the_DT
cause_NN
of_IN
cortisol_NN
resistance_NN
._.

Total_JJ
RNA_NN
isolated_VBN
from_IN
the_DT
index_NN
subject_NN
's_POS
mononuclear_JJ
leukocytes_NNS
was_VBD
used_VBN
to_TO
produce_VB
first_JJ
strand_NN
hGR_NN
cDNAs_NNS
,_,
and_CC
the_DT
entire_JJ
hGR_NN
cDNA_NN
was_VBD
amplified_VBN
in_IN
segments_NNS
and_CC
sequenced_VBN
._.

At_IN
nucleotide_NN
2,317_CD
we_PRP
identified_VBD
a_DT
homozygous_JJ
A_NN
for_IN
G_NN
point_NN
mutation_NN
that_WDT
predicts_VBZ
an_DT
isoleucine_NN
-LRB-_-LRB-
ATT_NN
-RRB-_-RRB-
for_IN
valine_NN
-LRB-_-LRB-
GTT_NN
-RRB-_-RRB-
substitution_NN
at_IN
amino_NN
acid_NN
729_CD
._.

When_WRB
the_DT
wild-type_JJ
hGR_NN
and_CC
hGR-Ile_NN
729_CD
were_VBD
expressed_VBN
in_IN
COS-1_NN
cells_NNS
and_CC
assayed_VBN
for_IN
-LCB-_-LRB-
3H-RCB_JJ
--_JJ
Dexamethasone_NN
binding_NN
,_,
the_DT
dissociation_NN
constants_NNS
were_VBD
0.799_CD
+_CC
\/_CD
-_:
0.068_CD
and_CC
1.54_CD
+_JJ
\/_:
-_:
0.06_CD
nM_NN
-LRB-_-LRB-
mean_CD
+_CC
\/_NN
-_:
SEM_NN
-RRB-_-RRB-
-LRB-_-LRB-
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
,_,
respectively_RB
._.

When_WRB
the_DT
wild-type_JJ
hGR_NN
and_CC
hGR-Ile_NN
729_CD
were_VBD
expressed_VBN
in_IN
CV-1_NN
cells_NNS
that_WDT
were_VBD
cotransfected_VBN
with_IN
the_DT
mouse_NN
mammary_JJ
tumor_NN
virus_NN
long_JJ
terminal_JJ
repeat_NN
fused_VBN
to_TO
the_DT
chloramphenicol_NN
acetyl_NN
transferase_NN
-LRB-_-LRB-
CAT_NN
-RRB-_-RRB-
gene_NN
,_,
the_DT
hGR-Ile_NN
729_CD
conferred_VBD
a_DT
fourfold_JJ
decrease_NN
in_IN
apparent_JJ
potency_NN
on_IN
dexamethasone_NN
stimulation_NN
of_IN
CAT_NN
activity_NN
._.

The_DT
isoleucine_NN
for_IN
valine_NN
substitution_NN
at_IN
amino_NN
acid_NN
729_CD
impairs_VBZ
the_DT
function_NN
of_IN
the_DT
hGR_NN
and_CC
is_VBZ
the_DT
likely_JJ
cause_NN
of_IN
primary_JJ
cortisol_NN
resistance_NN
in_IN
this_DT
subject_NN
._.

